Log in to save to my catalogue

Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus

Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_inserm_02277186v1

Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus

About this item

Full title

Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Endocrinology, 2019-10, Vol.15 (10), p.569-589

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Despite its position as the first-line drug for treatment of type 2 diabetes mellitus, the mechanisms underlying the plasma glucose level-lowering effects of metformin (1,1-dimethylbiguanide) still remain incompletely understood. Metformin is thought to exert its primary antidiabetic action through the suppression of hepatic glucose production. In...

Alternative Titles

Full title

Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_inserm_02277186v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_inserm_02277186v1

Other Identifiers

ISSN

1759-5029

E-ISSN

1759-5037

DOI

10.1038/s41574-019-0242-2

How to access this item